Recent studies have demonstrated that the dysregulation of RRM2 is associated with certain types of malignancy, including renal cell carcinoma [11], lung cancer [12,13], glioblastoma [14], and breast cancer [15]. The gene discussed is RRM2; the disease is renal cell carcinoma.